Policy· June 21, 2026 · 5 min readBuilding the AMCP dossier: a guide to the version 5.0 format and value evidence templateA comprehensive guide to the AMCP Format for Formulary Submissions Version 5.0, detailing digital therapeutics, real-world evidence,...By Ran Chen#AMCP Dossier#Market Access#Formulary Strategy
Pricing & Access· May 22, 2026 · 12 min readAMCP dossier evidence gaps that weaken payer review for a new specialty drugKey AMCP dossier evidence gaps that weaken payer review, from unclear value propositions to missing RWE, HEOR methods, and formulary...By Ran Chen#AMCP Dossier#Formulary#Payer Review
Pipeline· May 22, 2026 · 13 min readPatient-reported outcome endpoint translation from trial evidence to payer evidenceHow patient-reported outcome endpoints move from FDA trial evidence to payer evidence, and where PRO instruments, MCIDs, comparators,...By Ran Chen#Clinical Evidence#Payer Policy#AMCP Dossier